Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
07/2004
07/29/2004US20040146854 Attenuated forms of bovine viral diarrhea virus
07/29/2004US20040146846 Storage and maintenance of blood products including red blood cells and platelets
07/29/2004US20040146530 Avian vaccine effective against infectious bursal disease virus
07/29/2004US20040146528 MVA expressing modified HIV envelope, gag, and pol genes
07/29/2004US20040146490 Antibacterial therapy for multi-drug resistant bacteria
07/29/2004US20040146488 Gene expression of protein with ability to chaperon antigenic peptides of tumor cells to antigen-presenting cells (APCs); selective replication in and killilng of tumor cells; immunotherapy; antimetastasis and anticarcinogenic agents
07/29/2004DE10045016B4 Retrovirale Vektoren mit Fremdsequenzinsertion zwischen retroviraler Primerbindungsstelle und retroviralem Spleißdonor Retroviral vectors with Fremdsequenzinsertion between retroviral primer binding site and retroviral splice donor
07/29/2004CA2513025A1 Dual expression vector system for antibody expression in bacterial and mammalian cells
07/28/2004EP1441033A2 Eukaryotic gene expression cassette based on Herpes simplex virus
07/28/2004EP1440149A2 Infectious and attenuated bovine viral diarrhea virus clones; methods for their production and use
07/28/2004EP1440087A2 Mycobacterial genes down-regulated during latency
07/28/2004EP1439856A1 Recombinant rabies vaccine and methods of preparation and use
07/28/2004EP0728214B1 Stable cell lines capable of expressing the adeno-associated virus replication gene
07/28/2004CN1516733A Materials and methods relating to increasing viral titre
07/27/2004US6767699 Viral purification; mix viral preparation and ion exchange resins, remove unbound viral particles, elute bound viral particles, recover preferential replicon
07/27/2004CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
07/24/2004CA2418004A1 Multiplex assays for detection and identification of viral respiratory pathogens
07/22/2004WO2004061093A1 Immunizing fish against viral infection
07/22/2004WO2004060912A2 Chimeric capsid proteins and expression vectors for monocistronic expression of multiple genes
07/22/2004WO2003085084A3 Hepatitis c virus sub-genomic replicons
07/22/2004WO2003077853A9 Immortal porcine cells
07/22/2004WO2003039477A3 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
07/22/2004WO2003031583A3 Generation of virus-like particles by vsv
07/22/2004US20040142476 Organellar targeting of RNA and its use in the interruption of environmental gene flow
07/22/2004US20040142470 Recombinase-based system for construction of adenovirus vectors
07/22/2004US20040142451 one linker, a biomolecule coupled to the linker, and cyclohexane derivatives
07/22/2004US20040142449 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells
07/22/2004US20040142448 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
07/22/2004US20040142320 use of cells capable or carrying out a process of prenylation of proteins coded by the hepatitis C virus (HCV) genome for diagnosis/drug screening; antibiotic resistance
07/22/2004US20040142004 Avian pneumovirus vaccine
07/22/2004US20040142003 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase
07/22/2004US20040141991 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation.
07/21/2004EP1438969A1 Arterivirus marker vaccine
07/21/2004EP1438399A2 Paramyxoviruses as gene transfer vectors to lung cells
07/21/2004EP1438075A2 Methods and compositions relating to restricted expression lentiviral vectors and their applications
07/21/2004EP1438066A1 Incapacitated whole-cell immunogenic bacterial compositions
07/21/2004EP1437961A2 Methods of suppressing microglial activation
07/21/2004EP1268833B1 Modified nodavirus rna for gene delivery
07/21/2004CN1514734A Composition and method for increasing cell density in cell cultures infected with lentivirus
07/21/2004CN1514688A Oncolytic virus therapy
07/21/2004CN1513996A Marek's disease virus vaccine CV1988 strain VP22 gene
07/21/2004CN1513987A Recombination pseudorabies virus for expressing pig breeding and respiration comproehensive oyndrome virus and application
07/21/2004CN1513553A Vero cell fick-borne encephalitis inactivated vaccine
07/20/2004US6764995 Uses as an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression
07/20/2004US6764685 Chimeric viruses; cdna or rna used to express heterologous gene products in host cell systems and/or to rescue negative strand rna recombinant viruses
07/20/2004US6764684 Avian herpesvirus-based recombinant infectious bursal disease vaccine
07/20/2004US6764676 Attenuated fiv-141 virus with deletion mutation in the env gene; vaccines; replicates upon entry to host cell
07/15/2004WO2004058953A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
07/15/2004WO2004058801A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy
07/15/2004WO2004034956A3 8-plasmid method with mutated ha gene for producing an influenza vaccine
07/15/2004WO2004027048A3 High titer recombinant aav production
07/15/2004WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold
07/15/2004WO2003093431A3 Ablated slam-dependent entry
07/15/2004WO2003089612A3 IMPROVED rAAV VECTORS
07/15/2004US20040137627 Using sendai viral vector as tool for transfer and expression of heterologous nucleotide sequences
07/15/2004US20040137599 Leporipox-based vector vaccines
07/15/2004US20040137015 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics
07/15/2004US20040137013 Live vaccine and method of manufacture
07/15/2004US20040136963 Simian adenovirus vectors and methods of use
07/15/2004US20040136962 Ordered molecular presetation of antigens, method of preparation and use
07/15/2004CA2511625A1 Modified vaccinia ankara expressing p53 in cancer immunotherapy
07/15/2004CA2511243A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
07/14/2004EP1437593A1 Method of examining (-)-strand rna virus vector having lowered ability to form grains and method of constructing the same
07/14/2004EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
07/14/2004EP1436058A1 Separation medium, its preparation and its use
07/14/2004EP1436056A2 Macroporous gel, its preparation and its use
07/14/2004EP1436001A1 Chicken anemia virus vaccine from cell line
07/14/2004EP1435788A2 Lysin-deficient bacteriophages having reduced immunogenicity
07/14/2004EP0954566B1 Nonoxynol-containing lipid vesicles with anti-viral and spermacidal activity
07/14/2004CN1511947A Gene expression preventing chronic transplanting rejection of recombined gland relative virus mediated haem oxidase-1 (HO-1)
07/14/2004CN1511587A Process for preparing Vero cell epidemic cold purified vaccine and its use
07/14/2004CN1157479C Virus expression veclor of tomato flower-leaf virus low virulent strain K
07/13/2004USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias
07/13/2004US6762031 Viral expression library for use as tools in gene therapy
07/13/2004US6761893 Modified vaccinia ankara virus variant
07/13/2004CA2163212C Therapeutic compounds
07/13/2004CA2118862C Bovine ovary cell line (frov) for virus replication
07/08/2004WO2004057021A2 Molecular methods and compositions for detecting and quantifying respiratory viruses
07/08/2004WO2004056979A2 Recombinant virus production for the manufacturing of vaccines
07/08/2004WO2004056977A1 Production of alvac on avian embryonic stem cells
07/08/2004WO2004035779A8 Biomolecule transfer method using virus envelope and composition and system therefor
07/08/2004WO2004003143A3 Viruses and virus-like particles for multiple antigen and target display
07/08/2004WO2002081655A3 Fusion protein construct and method for inducing hiv-specific serum igg and secretory iga antibodies in-vivo
07/08/2004US20040133942 Comprises insecticidal protein against lepidopteran insect pests; biological pest control and tissue engineering
07/08/2004US20040133356 Three-dimensional model of a Fc region of an IgE antibody and uses thereof
07/08/2004US20040132678 Recombinant double-stranded RNA phage, and use of the same
07/08/2004US20040132178 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
07/08/2004US20040132162 Chimeric papillomavirus-like particles
07/08/2004US20040132014 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
07/08/2004US20040132012 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases
07/08/2004US20040132007 Modified virus
07/08/2004US20040131640 Escape mutants of newcastle disease virus as marker vaccines
07/08/2004US20040131639 Novel recombinant tryptophan mutants of influenza
07/08/2004US20040131594 Malaria therapy; using pox virus vectors; genetic engineering; antitumor agents
07/08/2004US20040131592 Gene expression of alphavirus; nucleotide sequences; induce immunology response; aids vaccine
07/08/2004US20040131497 Process for sterilization of biological compositions containg protein
07/08/2004DE10221411B4 Rekombinantes Fowlpox-Virus Recombinant fowlpox virus
07/08/2004CA2510229A1 Production of alvac on avian embryonic stem cells
07/08/2004CA2501975A1 Recombinant virus production for the manufacturing of vaccines
07/07/2004EP1435387A1 The oncolytic microorganisms expressing hsp and uses thereof